INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer
Clinical trial NCT06747832 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06747832
- Sponsor
- Guangzhou Ruixin Biotechnological Co., LTD
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-15
- Primary completion
- 2026-06-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.